Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramkrishna

Showing results (551-560 of 557) with videos related to

Pageof 56
Sort By:
You have reached the last page of results.This site can display upto 557 results.
Radiology. Artificial Intelligence|January 21, 2026
Development of a Deep Learning Algorithm for Posterior Fossa Abnormality Recognition on First-Trimester US Screening Scans: AIRFRAME Study Part 1Alessandra Familiari, Chiara Di Ilio, Andrea Dall'Asta, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Mabs|December 9, 2016
Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degenerationKun Ding, Lucia Eaton, Diana Bowley, et al.
Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCCPablo Llerena, Hani Samarah, Kathryn Nunes, et al.
Frontiers in Immunology|March 8, 2024
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβYunhao Tan, Kenta Mosallanejad, Qingxiu Zhang, et al.
Pageof 56

Showing results (551-560 of 557) with videos related to

Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 557 results.
Radiology. Artificial Intelligence|January 21, 2026
Development of a Deep Learning Algorithm for Posterior Fossa Abnormality Recognition on First-Trimester US Screening Scans: AIRFRAME Study Part 1Alessandra Familiari, Chiara Di Ilio, Andrea Dall'Asta, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Mabs|December 9, 2016
Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degenerationKun Ding, Lucia Eaton, Diana Bowley, et al.
Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCCPablo Llerena, Hani Samarah, Kathryn Nunes, et al.
Frontiers in Immunology|March 8, 2024
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβYunhao Tan, Kenta Mosallanejad, Qingxiu Zhang, et al.
Pageof 56